To include your compound in the COVID-19 Resource Center, submit it here.

CoMMpass study allows real-time patient decisions

On Monday, the Multiple Myeloma Research Foundation (MMRF) said the patient-led and conceived CoMMpass study has been amended to allow physicians to use genomic

Read the full 246 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE